CRBP · Company research
Corbus Pharmaceuticals Holdings, Inc. (CRBP): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings Insiders Lose Out As Stock Sinks To US$5.38 - Simply Wall Street | Corbus Pharmaceuticals Holdings Insiders Lose Out As Stock Sinks To US$5.38 Simply Wall Street | View source ↗ | Simply Wall Street | Oct 10, 2026 | neutral | 0 | 0.6 |
| Corbus Pharmaceuticals (CRBP) Short Interest & Short Float | Updated Oct 2026 - MarketBeat | Corbus Pharmaceuticals (CRBP) Short Interest & Short Float | Updated Oct 2026 MarketBeat | View source ↗ | MarketBeat | Oct 9, 2026 | neutral | 0 | 0.6 |
| CRBP Oct 2026 15.000 call (CRBP261016C00015000) Interactive Stock Chart - Yahoo! Finance Canada | CRBP Oct 2026 15.000 call (CRBP261016C00015000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 4, 2026 | neutral | 0 | 0.6 |
| CRBP Oct 2026 20.000 call (CRBP261016C00020000) Stock Historical Prices & Data - Yahoo! Finance Canada | CRBP Oct 2026 20.000 call (CRBP261016C00020000) Stock Historical Prices & Data Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 4, 2026 | neutral | 0 | 0.6 |
| Four parties report the same Corbus (CRBP) stake, held directly by one fund. - Stock Titan | Four parties report the same Corbus (CRBP) stake, held directly by one fund. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| About 14,000 U.S. patients may qualify yearly for another throat cancer treatment. Corbus doses its first trial patient. - Stock Titan | About 14,000 U.S. patients may qualify yearly for another throat cancer treatment. Corbus doses its first trial patient. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) Stock Forecast & Analyst Predictions - Simply Wall Street | Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 14, 2026 | neutral | 0 | 0.6 |
| $CRBP stock is down 8% today. Here's what we see in our data. - Quiver Quantitative | $CRBP stock is down 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 9, 2026 | neutral | 0 | 0.6 |
| (CRBP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily | (CRBP) as a Liquidity Pulse for Institutional Tactics Stock Traders Daily | View source ↗ | Stock Traders Daily | Jul 23, 2026 | neutral | 0 | 0.6 |
| CRBP Forecast — Price Target — Prediction for 2027 - TradingView | CRBP Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Price: Oct 7 Close $5.49 - Gotrade | Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Price: Oct 7 Close $5.49 Gotrade | View source ↗ | Gotrade | May 29, 2026 | neutral | 0 | 0.6 |
| Corbus Pharmaceuticals: I'd Preach Caution After Selloff On Latest Data Drop (NASDAQ:CRBP) - Seeking Alpha | Corbus Pharmaceuticals: I'd Preach Caution After Selloff On Latest Data Drop (NASDAQ:CRBP) Seeking Alpha | View source ↗ | Seeking Alpha | May 27, 2026 | neutral | 0 | 0.6 |
| Corbus Pharmaceuticals Stock (CRBP) Opinions on Updated CRB-701 Cancer Data Release - Quiver Quantitative | Corbus Pharmaceuticals Stock (CRBP) Opinions on Updated CRB-701 Cancer Data Release Quiver Quantitative | View source ↗ | Quiver Quantitative | May 26, 2026 | neutral | 0 | 0.6 |
| Corbus Pharma (CRBP) Faces Premarket Decline Following Phase 1/2 Trial Data - GuruFocus | Corbus Pharma (CRBP) Faces Premarket Decline Following Phase 1/2 Trial Data GuruFocus | View source ↗ | GuruFocus | May 26, 2026 | neutral | 0 | 0.6 |
| Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value - Yahoo Finance | Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value Yahoo Finance | View source ↗ | Yahoo Finance | Apr 17, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.